LAG-3 inhibitor
Showing 1 - 25 of >10,000
Psoriasis, Atopic Dermatitis Trial in Taipei (UVB treatment)
Recruiting
- Psoriasis
- Atopic Dermatitis
- UVB treatment
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 24, 2022
Tumor, Solid Trial in Xiamen (68Ga-DOTA-hLAG-3 PET/CT)
Recruiting
- Tumor, Solid
- 68Ga-DOTA-hLAG-3 PET/CT
-
Xiamen, Fujian, ChinaThe First affiliated hospital of xiamen university
May 8, 2022
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
Advanced NSCLC Trial in Shanghai (GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin,
Not yet recruiting
- Advanced Non-Small Cell Lung Cancer
- GLS-012+GLS-010
- +2 more
-
Shanghai, Shanghai, ChinaShang Hai Pulmonary Hospital
Aug 3, 2023
Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)
Recruiting
- Advanced Cancer
- Relatlimab
- +3 more
-
Duarte, California
- +23 more
Oct 24, 2022
Neoadjuvant, Immunotherapy, Sarcoma,Soft Tissue Trial in Warsaw (Pembrolizumab, Eftilagimod alpha)
Recruiting
- Neoadjuvant
- +3 more
- Pembrolizumab, Eftilagimod alpha
-
Warsaw, PolandMaria Sklodowska-Curie National Research Institute of Oncology
Nov 7, 2023
Advanced Malignant Tumors(Stage IA-IB) Trial in Beijing (AK129 IV infusion)
Not yet recruiting
- Advanced Malignant Tumors(Stage IA-IB)
- AK129 IV infusion
-
Beijing, Beijing, ChinaCancer Hospital Chinese Academy of Medical Science
Jan 17, 2023
Breast Carcinoma Trial in Houston (biological, drug, other)
Not yet recruiting
- Breast Carcinoma
- eftilagimod alpha
- +2 more
-
Houston, TexasOncology Consultants
Feb 17, 2023
Myopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in Contrast Trial in Waterloo (DOT Pattern,
Recruiting
- Myopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in Contrast
- DOT Pattern
- Control Spectacles
-
Waterloo, Ontario, CanadaCentre for Ocular Research and Education
Dec 20, 2021
Efficacy of Immunotherapy in Hepatocellular Carcinoma
Recruiting
- Hepatocellular Carcinoma
- CTC PD-L1, exosomal PD-L1, and exosomal LAG-3 detection
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Oct 20, 2022
Iron, Alpha-Synuclein, and Lymphocyte-activation Gene-3 in
Not yet recruiting
- Brain Ischemia
- Serum Iron
- +7 more
-
Aswan, EgyptAswan University Hospital
Mar 7, 2023
Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain Trial in Los Angeles, Torrance (Tart
Not yet recruiting
- Breast Cancer
- +2 more
- Tart Cherry
- Omega 3 FA (Fish Oil)
-
Los Angeles, California
- +1 more
Nov 7, 2023
Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)
Not yet recruiting
- Metastatic Colorectal Cancer
- (no location specified)
Oct 31, 2023
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Pittsburgh (Nivolumab, Relatlimab, Ipilimumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Nivolumab
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Mar 31, 2022
Solid Tumor, Adult, Lymphoma Trial in Shanghai (HLX26)
Recruiting
- Solid Tumor, Adult
- Lymphoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 10, 2022
Relapsed or Refractory Lymphoma Trial in Miami (Itraconazole 200 mg, Fluconazole 400 mg, Rifampin 600 mg)
Completed
- Relapsed or Refractory Lymphoma
- Itraconazole 200 mg
- +3 more
-
Miami, FloridaQPS- Miami
Jan 12, 2023
Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Durvalumab
- Rintatolimod
-
Rotterdam, Zuid-Holland, NetherlandsErasmus MC
Jun 23, 2023
Pre-Eclampsia Trial (real time PCR)
Not yet recruiting
- Pre-Eclampsia
- real time PCR
- (no location specified)
Mar 22, 2022
Breast Cancer Trial in Guangzhou (Capecitabine, Aromatase Inhibitor)
Active, not recruiting
- Breast Cancer
- Capecitabine
- Aromatase Inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Oncology in South China, Sun Yat-sen Uni
Jan 27, 2023
Healthy Volunteers Trial (Brensocatib, Clarithromycin)
Not yet recruiting
- Healthy Volunteers
- (no location specified)
Jul 19, 2023